HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Infectious Disease
Meta-analysis
Vaccines show protective effects against rotavirus and pneumococcal disease in sub-Saharan African children.
Vaccine Results Might Be Wrong Without These Factors
This systematic review and meta-analysis of 64 studies assessed vaccine effectiveness in children under five years in sub-Saharan Africa. Ro…
Vaccine studies in Africa often miss other health changes happening at the same time, which can make shots look more effective than they rea…
medRxiv
Apr 14, 2026
Allergy & Immunology
ACIP Updates Recommendations for Pneumococcal Vaccine Use in U.S. Adults
Health Panel Updates Pneumococcal Vaccine Recommendations for U.S. Adults
The Advisory Committee on Immunization Practices (ACIP) has issued updated recommendations for pneumococcal vaccine use in U.S. adults aged …
New U.S. guidelines now recommend specific pneumococcal vaccines for all adults aged 19 and older to protect against pneumonia and meningiti…
CDC
Apr 4, 2026
Pediatrics
ACIP recommends 20-valent pneumococcal conjugate vaccine for children in the United States
Should your child get the new pneumococcal vaccine? Health advisors say yes.
The Advisory Committee on Immunization Practices (ACIP) has updated its recommendations to include the 20-valent pneumococcal conjugate vacc…
A major U.S. health panel now recommends a new vaccine for children that guards against more strains of bacteria causing pneumonia and menin…
CDC
Apr 4, 2026
Allergy & Immunology
ACIP recommends 15-valent pneumococcal conjugate vaccine for U.S. children
What's the latest vaccine recommendation for protecting U.S. children from pneumococcal disease?
The Advisory Committee on Immunization Practices issued updated recommendations for using the 15-valent pneumococcal conjugate vaccine in U.…
Health officials updated 2022 vaccine guidance to include a new option protecting U.S. children against 15 strains of pneumococcal bacteria.
CDC
Apr 4, 2026
Allergy & Immunology
CDC Updates Pneumococcal Conjugate Vaccine Recommendation for Adults Aged 50+
Who should get the pneumonia vaccine? CDC updates recommendations for adults over 50.
The CDC has updated its pneumococcal conjugate vaccine recommendation for adults aged 50 years or older who are PCV-naïve or have unknown va…
CDC now recommends the pneumonia vaccine for all adults over 50 who have never received it or don't know their vaccination history.
CDC
Apr 3, 2026
Allergy & Immunology
ACIP Recommends 21-Valent Pneumococcal Conjugate Vaccine as Option for Some U.S. Adults
U.S. health advisors recommend new pneumococcal vaccine option for adults
The Advisory Committee on Immunization Practices has issued a recommendation report for U.S. adults. The committee recommends the 21-valent …
U.S. health advisors now list a new 21-valent pneumococcal vaccine as an option for some adults to help prevent pneumonia and meningitis.
CDC
Apr 3, 2026